These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Resveratrol modulates the phosphoinositide 3-kinase pathway through an estrogen receptor alpha-dependent mechanism: relevance in cell proliferation. Pozo-Guisado E, Lorenzo-Benayas MJ, Fernández-Salguero PM. Int J Cancer; 2004 Mar 20; 109(2):167-73. PubMed ID: 14750165 [Abstract] [Full Text] [Related]
3. Up-regulation of PI3K/Akt signaling by 17beta-estradiol through activation of estrogen receptor-alpha, but not estrogen receptor-beta, and stimulates cell growth in breast cancer cells. Lee YR, Park J, Yu HN, Kim JS, Youn HJ, Jung SH. Biochem Biophys Res Commun; 2005 Nov 04; 336(4):1221-6. PubMed ID: 16169518 [Abstract] [Full Text] [Related]
4. Glycogen synthase kinase 3 has a limited role in cell cycle regulation of cyclin D1 levels. Yang K, Guo Y, Stacey WC, Harwalkar J, Fretthold J, Hitomi M, Stacey DW. BMC Cell Biol; 2006 Aug 30; 7():33. PubMed ID: 16942622 [Abstract] [Full Text] [Related]
5. Phosphatidylinositol-3-OH Kinase (PI3K)/AKT2, activated in breast cancer, regulates and is induced by estrogen receptor alpha (ERalpha) via interaction between ERalpha and PI3K. Sun M, Paciga JE, Feldman RI, Yuan Z, Coppola D, Lu YY, Shelley SA, Nicosia SV, Cheng JQ. Cancer Res; 2001 Aug 15; 61(16):5985-91. PubMed ID: 11507039 [Abstract] [Full Text] [Related]
6. Nectandrin B activates endothelial nitric-oxide synthase phosphorylation in endothelial cells: role of the AMP-activated protein kinase/estrogen receptor α/phosphatidylinositol 3-kinase/Akt pathway. Hien TT, Oh WK, Nguyen PH, Oh SJ, Lee MY, Kang KW. Mol Pharmacol; 2011 Dec 15; 80(6):1166-78. PubMed ID: 21940786 [Abstract] [Full Text] [Related]
7. delta-Opioid receptor-stimulated Akt signaling in neuroblastoma x glioma (NG108-15) hybrid cells involves receptor tyrosine kinase-mediated PI3K activation. Heiss A, Ammer H, Eisinger DA. Exp Cell Res; 2009 Jul 15; 315(12):2115-25. PubMed ID: 19362548 [Abstract] [Full Text] [Related]
8. An inherent role of integrin-linked kinase-estrogen receptor alpha interaction in cell migration. Acconcia F, Manavathi B, Mascarenhas J, Talukder AH, Mills G, Kumar R. Cancer Res; 2006 Nov 15; 66(22):11030-8. PubMed ID: 17108142 [Abstract] [Full Text] [Related]
9. Estrogen receptor beta signaling through phosphatase and tensin homolog/phosphoinositide 3-kinase/Akt/glycogen synthase kinase 3 down-regulates blood-brain barrier breast cancer resistance protein. Hartz AM, Madole EK, Miller DS, Bauer B. J Pharmacol Exp Ther; 2010 Aug 15; 334(2):467-76. PubMed ID: 20460386 [Abstract] [Full Text] [Related]
10. Insulin-like growth factor binding protein-4 and -5 modulate ligand-dependent estrogen receptor-α activation in breast cancer cells in an IGF-independent manner. Hermani A, Shukla A, Medunjanin S, Werner H, Mayer D. Cell Signal; 2013 Jun 15; 25(6):1395-402. PubMed ID: 23499909 [Abstract] [Full Text] [Related]
11. WNT unrelated activities in commercially available preparations of recombinant WNT3a. Cajanek L, Adlerz L, Bryja V, Arenas E. J Cell Biochem; 2010 Dec 01; 111(5):1077-9. PubMed ID: 20665540 [Abstract] [Full Text] [Related]
12. Forkhead box transcription factor FOXO3a regulates estrogen receptor alpha expression and is repressed by the Her-2/neu/phosphatidylinositol 3-kinase/Akt signaling pathway. Guo S, Sonenshein GE. Mol Cell Biol; 2004 Oct 01; 24(19):8681-90. PubMed ID: 15367686 [Abstract] [Full Text] [Related]
13. Akt stabilizes estrogen receptor alpha with the concomitant reduction in its transcriptional activity. Park S, Song J, Joe CO, Shin I. Cell Signal; 2008 Jul 01; 20(7):1368-74. PubMed ID: 18450422 [Abstract] [Full Text] [Related]
14. High glucose impaired estrogen receptor alpha signaling via β-catenin in osteoblastic MC3T3-E1. Wang R, Gao D, Zhou Y, Chen L, Luo B, Yu Y, Li H, Hu J, Huang Q, He M, Peng W, Luo D. J Steroid Biochem Mol Biol; 2017 Nov 01; 174():276-283. PubMed ID: 29030155 [Abstract] [Full Text] [Related]
15. Insulin-like growth factor-I inhibits progesterone receptor expression in breast cancer cells via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway: progesterone receptor as a potential indicator of growth factor activity in breast cancer. Cui X, Zhang P, Deng W, Oesterreich S, Lu Y, Mills GB, Lee AV. Mol Endocrinol; 2003 Apr 01; 17(4):575-88. PubMed ID: 12554765 [Abstract] [Full Text] [Related]
16. Cross-talk between IGF-I and estradiol in the brain: focus on neuroprotection. Garcia-Segura LM, Sanz A, Mendez P. Neuroendocrinology; 2006 Apr 01; 84(4):275-9. PubMed ID: 17124377 [Abstract] [Full Text] [Related]
17. Glycogen synthase kinase 3 beta is a natural activator of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 1 (MEKK1). Kim JW, Lee JE, Kim MJ, Cho EG, Cho SG, Choi EJ. J Biol Chem; 2003 Apr 18; 278(16):13995-4001. PubMed ID: 12584189 [Abstract] [Full Text] [Related]
18. Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor alpha (ERalpha), differentially affect ERalpha extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer cells. Marsaud V, Gougelet A, Maillard S, Renoir JM. Mol Endocrinol; 2003 Oct 18; 17(10):2013-27. PubMed ID: 12855746 [Abstract] [Full Text] [Related]
19. Gonadotropin-induced apoptosis in human ovarian surface epithelial cells is associated with cyclooxygenase-2 up-regulation via the beta-catenin/T-cell factor signaling pathway. Pon YL, Wong AS. Mol Endocrinol; 2006 Dec 18; 20(12):3336-50. PubMed ID: 16945989 [Abstract] [Full Text] [Related]
20. Regulation of the RAP1/RAF-1/extracellularly regulated kinase-1/2 cascade and prolactin release by the phosphoinositide 3-kinase/AKT pathway in pituitary cells. Romano D, Pertuit M, Rasolonjanahary R, Barnier JV, Magalon K, Enjalbert A, Gerard C. Endocrinology; 2006 Dec 18; 147(12):6036-45. PubMed ID: 16935846 [Abstract] [Full Text] [Related] Page: [Next] [New Search]